A detailed history of First Command Financial Services, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, First Command Financial Services, Inc. holds 8,668 shares of ABT stock, worth $1.02 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
8,668
Previous 9,211 5.9%
Holding current value
$1.02 Million
Previous $932,000 1.29%
% of portfolio
0.09%
Previous 0.1%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 21, 2023

SELL
$100.78 - $112.29 $54,723 - $60,973
-543 Reduced 5.9%
8,668 $944,000
Q1 2023

Apr 14, 2023

SELL
$96.86 - $114.01 $66,155 - $77,868
-683 Reduced 6.9%
9,211 $932,000
Q4 2022

Jan 20, 2023

BUY
$95.06 - $111.52 $10,551 - $12,378
111 Added 1.13%
9,894 $1.09 Million
Q3 2022

Oct 24, 2022

SELL
$96.76 - $112.03 $9,676 - $11,203
-100 Reduced 1.01%
9,783 $947,000
Q2 2022

Jul 21, 2022

BUY
$102.07 - $123.37 $2,143 - $2,590
21 Added 0.21%
9,883 $1.07 Million
Q1 2022

Apr 14, 2022

BUY
$114.02 - $139.04 $29,645 - $36,150
260 Added 2.71%
9,862 $1.17 Million
Q4 2021

Jan 25, 2022

BUY
$115.53 - $141.46 $95,081 - $116,421
823 Added 9.37%
9,602 $1.35 Million
Q3 2021

Jan 12, 2022

BUY
$116.66 - $129.06 $28,581 - $31,619
245 Added 2.87%
8,779 $1.04 Million
Q2 2021

Jul 20, 2021

BUY
$105.79 - $124.53 $39,988 - $47,072
378 Added 4.63%
8,534 $989,000
Q1 2021

Apr 20, 2021

SELL
$108.84 - $128.23 $26,448 - $31,159
-243 Reduced 2.89%
8,156 $977,000
Q3 2020

Oct 19, 2020

BUY
$91.64 - $111.29 $138,101 - $167,714
1,507 Added 21.87%
8,399 $914,000
Q2 2020

Jul 20, 2020

SELL
$76.57 - $98.0 $183,002 - $234,220
-2,390 Reduced 25.75%
6,892 $631,000
Q2 2020

Jul 17, 2020

BUY
$76.57 - $98.0 $223,814 - $286,454
2,923 Added 45.97%
9,282 $850,000
Q1 2020

Apr 20, 2020

BUY
$62.82 - $91.86 $39,388 - $57,596
627 Added 10.94%
6,359 $502,000
Q4 2019

Jan 14, 2020

SELL
$78.51 - $87.4 $7,851 - $8,740
-100 Reduced 1.71%
5,732 $498,000
Q3 2019

Oct 21, 2019

BUY
$81.84 - $88.74 $17,431 - $18,901
213 Added 3.79%
5,832 $488,000
Q2 2019

Jul 15, 2019

SELL
$72.88 - $85.0 $35,128 - $40,970
-482 Reduced 7.9%
5,619 $473,000
Q1 2019

Apr 15, 2019

BUY
$66.22 - $80.06 $9,668 - $11,688
146 Added 2.45%
6,101 $488,000
Q4 2018

Jan 24, 2019

BUY
$65.56 - $74.27 $390,409 - $442,277
5,955 New
5,955 $430,000
Q4 2018

Jan 24, 2019

SELL
$65.56 - $74.27 $149,935 - $169,855
-2,287 Closed
0 $0
Q2 2018

Jul 24, 2018

SELL
$57.57 - $63.54 $1,151 - $1,270
-20 Reduced 0.87%
2,287 $139,000
Q1 2018

Apr 12, 2018

SELL
$56.27 - $63.62 $2,926 - $3,308
-52 Reduced 2.2%
2,307 $138,000
Q3 2017

Oct 10, 2017

BUY
$48.06 - $53.64 $113,373 - $126,536
2,359
2,359 $126,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $205B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track First Command Financial Services, Inc. Portfolio

Follow First Command Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Command Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Command Financial Services, Inc. with notifications on news.